More importantly, this newly confirmed miR-1231/EGFR/PI3K/AKT axis provides an insight into the mechanisms underlying glioma development, and may aid the future development of novel molecular targeting therapeutics for human gliomas. The gene discussed is AKT1; the disease is glioma.